SAVA - Spark Newswire

1 minute read

Science Journal Finds No Evidence To Data Manipulation By Cassava Sciences’ In 2005 Publication

Today, 8:25 AM

Cassava Sciences Inc (NASDAQ: SAVA) has been informed by the Neuroscience journal that there is no evidence to support claims of data manipulation in a 2005 paper authored by the Company and its scientific collaborators.

SAVA

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 8:25 AM

ACAD

2 minute read

FDA
News

Cassava Sciences Says Science Journal Finds No Evidence To Support Claims Of Data Manipulation In 2005 Publication

By Benzinga Newsdesk

Today, 8:25 AM

Cassava Sciences, Inc., (NASDAQ:SAVA) a biotechnology company, has been informed by Neuroscience journal there is no evidence to support claims of data manipulation in a 2005 paper1 authored by the Company

SAVA

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 8:25 AM

ADTX

3 minute read

26 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 8:25 AM

Gainers

ADGI

5 minute read

65 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:25 AM

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.

AERC

1 minute read

Cassava Sciences Shares Move Lower; Traders Circulate JNeurosci Report Titled ‘Expression of Concern: Wang et al., “Reducing Amyloid-Related Alzheimer’s Disease Pathogenesis by a Small Molecule Targeting Filamin A”‘

By Benzinga Newsdesk

Today, 8:25 AM

https://www.jneurosci.org/content/early/2021/12/16/JNEUROSCI.2306-21.2021

SAVA

1 minute read

Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More

By Craig Jones

Today, 8:25 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Fulgent Genetics, Inc. (NASDAQ: FLGT) is a "mystery" to him. With the company doing quite well, he considers it a very good company.

CCL

1 minute read

Quick Take Technical Analysis: Cassava Sciences, Inc

By Melanie Schaffer

Today, 8:25 AM

Cassava Sciences, Inc (NASDAQ: SAVA) fell over 5% on Tuesday, amid a large overall market pullback that saw the SPDR S&P 500 (NYSE: SPY) decline about 1.8%.

SAVA

2 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 8:25 AM

AKYA

Feed Symbols: SAVA